A blood pressure medication has been recalled nationwide after failing FDA dissolution testing, a quality defect that can affect how the drug is absorbed in the body. Regulators have classified the action as a Class II recall, indicating a situation in which exposure may cause temporary or medically reversible adverse health consequences, though the likelihood of serious harm is considered remote.
"Nationwide Blood Pressure Drug Recall Raises Fresh Quality-Control Concerns"
A blood pressure medication has been recalled nationwide after failing FDA dissolution testing, a quality defect that can affect how the drug is absorbed in the body. Regulators have classified the action as a Class II recall, indicating a situation in which exposure may cause temporary or medically reversible adverse health consequences, though the likelihood of serious harm is considered remote.
Nationwide Blood Pressure Drug Recall Raises Fresh Quality-Control Concerns
RDU Global Wire
Global Markets & Equities Desk
A blood pressure medication has been recalled nationwide after failing FDA dissolution testing, a quality defect that can affect how the drug is absorbed in the body. Regulators have classified the action as a Class II recall, indicating a situation in which exposure may cause temporary or medically reversible adverse health consequences, though the likelihood of serious harm is considered remote.
Editorial & Verification Notice
Reported by RDU Global Correspondent. Formatted and verified using real-time institutional and journalistic wire feeds. Independent reporting adhering to the RDU Global Editorial Code of Conduct.
Related Coverage
Delaware Regulator Says It Was Misled in Probe of Mark Walter’s Insurance Assets
Delaware’s insurance regulator has said it was intentionally misled during its review of insurance assets linked to billionaire investor Mark Walter, intensifying scrutiny of a complex web of affiliated holdings. The dispute underscores how fragmented state oversight can leave regulators struggling to assess the true financial condition of large insurance groups with cross-ownership ties.
BILL Agrees to $6 Billion Take-Private by TPG and Corpay
BILL Holdings has agreed to be acquired by TPG in partnership with Corpay in a transaction valued at about $6 billion, marking one of the most significant take-private deals in the financial technology sector this year. The deal underscores continuing private equity appetite for scaled payments and finance software platforms as public market valuations remain under pressure.
Gold, Silver and Industrial Metals Slide as Strong Dollar and Higher-Yield Shock Hit Bullion
Gold and a broad cluster of precious and industrial metals were pushed to fresh lows as investors reacted to a firmer U.S. dollar, rising Treasury yields and renewed bets that the Federal Reserve may keep policy tighter for longer. The selloff deepened pressure on gold miners and related equities, underscoring how quickly the market has shifted from inflation-hedge demand to a higher-for-longer rates trade.
